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This paper presents a descriptive study, using the Birleson Scale to determine the frequency of depressive symptomatology in
children and adolescents with chronic renal insuﬃciency (CRI) undergoing hemodialysis (HD) and chronic peritoneal dialysis
(CPD). There were 67 patients (40 female and 27 male) with a mean age of 14.76 ± 2.71 years, duration of illness ≥3months,43
(64.18%) patients with CPD and 24 (35.82%) undergoing HD. The frequency of high occurrence, low occurrence, and absence of
depressive symptomatology was 10.45% (n = 7), 43.28% (n = 29), and 46.27% (n = 31), respectively; all of the seven (100%)
patients with high occurrence of depressive symptomatology were female (P = 0.04), and none of these (0%) had a friend to
conﬁde in (P = 0.03). Depressive symptomatology in patients with CPD was associated with a lower weekly Kt/V compared to
those without depressive symptomatology (2.15 ± 0.68 versus 2.52 ± 0.65; P = 0.01). There was no association with patient age,
caregiver, time and dialysis type, anemia, bone disease, nutritional or ﬁnancial status, origin, schooling, or employment.
1.Introduction
Depression is a public mental health problem that aﬀects
children, adolescents, and adults, negatively impacting their
personal, academic, social, and family lives [1]. In recent
years the prevalence of depression has increased worldwide,
and, at the same time, the presentation age has decreased.
According to the World Health Organization (WHO), this
makes it the medical condition with the fourth highest loss
of life years due to premature death or years living with a
severe and chronic incapacity [1].
The deﬁnition of depression is a mood alteration charac-
terized by a depressed state of mind, decreased enjoyment
and concentration, lack of interest, a feeling of disability,
guilt, and hopelessness, insomnia, reduced appetite, and su-
icide ideation. The earlier it is present, the greater the risk of
suicide, substance abuse, and behavioral problems; for this
reason it is very important to diagnose and treat quickly [2].
The prevalence of depression is about 3–5% in children
and around 8% in adolescents, with a female predominance
[3, 4]. The presence of depressive symptoms is about 15%.
These frequencies increase in patients with a chronic disease
[5].
Depression is the most common mental alteration in
patients with terminal chronic renal insuﬃciency, which is
neither diagnosed nor studied [5]. Livesley found that the
frequency of anxiety, personality disorder, and depression in
patients with chronic dialysis was signiﬁcantly higher than
in healthy individuals [6]. Lopes and colleagues found a
20% prevalence of depression in 5256 patients and 13.9%
in 9382 patients, both undergoing chronic hemodialysis
[7, 8]. Bakr and coworkers compared children undergoing
chronic hemodialysis with children not undergoing chronic
hemodialysis,ﬁndingthat52.6%ofthehemodialysispatients
had psychiatric alterations, and of these 10.3% had depres-
sion. The prevalence of depression changes according to the
studied population and the diagnostic method [9, 10].
Diﬀerent studies show an association between depres-
sion,decreaseinlengthoflife,andadherencetotherapy,with
an increase of 15 times the suicide risk and an increasing
number of hospitalizations. This makes it an independent
risk factor predicting mortality, and one with a signiﬁcant2 International Journal of Nephrology
Table 1: Correlation of high occurrence of depressive symptoms (score above 21 according to Birleson Scale) and absence of depressive
symptomatology (score below 13) with clinical, demographic, and social variables.
Variable High occurrence of depressive symptoms Absence of depressive symptoms P
n % n %
Gender
Female 7 100 19 61.29 0.04
Male 0 0 12 38.71
Provenance
Lima 5 71.43 17 54.84 0.82
Other cities 2 28.57 14 45.16
Attending school
Yes 1 4.35 14 60.87 0.2
No 6 13.64 17 38.64
Relationship age/level of education
Yes 4 57.14 13 41.94 0.18
No 3 42.86 18 58.06
Are you currently employed?
Yes 00 4 8 0 0.49
No 7 11.29 27 43.55
Socioeconomic level
Extreme poverty 3 9.38 15 46.88
0.4 No extreme poverty 4 17.39 8 34.78
No poverty 0 0 8 66.67
Family
Two-parent home 4 8.51 19 40.43
0.28 One-parent home 2 15.38 8 61.54
Others 1 14.29 4 57.14
Anemia
Yes 6 11.11 1 7.69 0.16
No 22 40.74 9 69.23
Renal osteodystrophy
Yes 2 28.57 22 70.97 0.16
No 5 71.43 9 29.03
Dialysis type
Hemodialysis 2 8.33 13 54.17 0.65
Peritoneal dialysis 5 11.63 18 41.86
Peritonitis
Yes 15 8 4 0 0.47
No 4 17.39 10 43.48
Nutritional status
Eutrophic 0 0 4 100
0.4 Mild chronic malnutrition 2 16.67 6 50
Moderate chronic malnutrition 2 8.7 9 39.13
Severe chronic malnutrition 3 10.71 12 42.86
Kt/V
Acceptable 5 71.43 23 74.19 0.45
Not acceptable 2 28.57 8 25.81
Friend to conﬁde in
Yes 0 0 17 54.84 0.03
No 7 100 14 45.16International Journal of Nephrology 3
Table 2: Correlation of depressive symptoms (score above 13 ac-
cordingtoBirlesonScale)andnodepressivesymptomswithclinical
and demographic variables.
Variable
Depressive
symptoms
No depressive
symptoms P < 0.05
x ±σ x ±σ
Patient’s age 14.67 ±2.89 14.10 ±2.78 0.33
Age of patient’s guardian 43.38 ±7.04 0 .16 ±7.44 0.1
Dialysis time 1.91 ±1.47 2.47 ±2.41 0.25
Hematocrit (%) 26.52 ±6.88 28.28 ±6.44 0.14
Parathormone (pg./mL) 277.37 ±245.11 309 ±385.86 0.68
Kt/V hemodialysis 1.45 ±0.19 1.39 ±0.28 0.43
Kt/V peritoneal dialysis 2.15 ±0.68 2.52 ±0.65 0.01
impact on the patient’s quality of life, greater than biological
or therapy factors [8, 11].
The principal objective of this study was to determine
the frequency of levels of depressive symptoms in children
withterminalchronicrenalinsuﬃciencyundergoingchronic
hemodialysis and chronic peritoneal dialysis and further
to ascertain whether there was a relationship with clinical,
demographic, or social factors. We used The Modiﬁed
Birleson Scale validated in Peru [10]. The adaptation of the
original test, Birleson Scale made by Peterson Birleson in
Englandin1981,usedinseveralstudies,wasmade,anditwas
evaluatedforexpertcouncil.Ithasdischargetrustworthiness.
2.MaterialsandMethods
The investigation was a descriptive, case series study. We
evaluated children with terminal chronic renal insuﬃciency
undergoing dialytic treatment for three months, at the
dialysis unit of the nephrology service of the Cayetano
Heredia Peruvian University.
We selected 84 patients with an average age of 14.76 ±
2.71 years, from which we excluded 14 because they were
under 8 years old, two who had Down’s syndrome, and
one who declined to participate in the study. Sixty-seven
patients (40 female and 27 male) fulﬁlled the inclusion
criteria (age between 8 and 18 years, duration of illness ≥3
months, no chronic comorbidities, accepted consent and
assent, stable clinically with no psychiatric or psychological
comorbidity diagnosed at that time, and knowledge of
writing). 43 (64.13%) chronic peritoneal dialysis patients
and24(35.82%)chronichemodialysispatientswereselected.
The Birleson Scale was used to determine the presence
of depression and depressive symptoms, being the value 13
as the cut-oﬀ score, where a score of 13–21 evidenced the
presence of depressive symptoms and a value of more than
21 demonstrated depression. While the Birleson Scale has
been used in disease states, it still has not been validated in
ESRD patients, and therefore high scores are suggestive but
not diagnostic of clinical depression. For this reason, those
variables were recategorized as high and low occurrence
of depressive symptomatology in terms of depression and
depressive symptoms, respectively, as well as, an absence of
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Low occurrence
of depressive
symptomatology
High occurrence
of depressive
symptomatology
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Figure 1: Correlation between depression symptomatology and
gender.
depressive symptoms if the score was <13 and the presence
of depressive symptoms ≥13.
Clinical data were collected from the patient charts
and sociodemographic data from the patients and their
caregivers.
Statistical Procedure. The statistical program Stata v.10 was
used for the data analysis. Chi2 and Student’s t were
employed todetermine statistical signiﬁcanceforcontinuous
and categorical variables, and variance analysis was used to
compare means.
3. Results
The frequency of high depressive symptomatology was
10.45% (n = 7), low depressive symptomatology 43.28%
(n = 29), and no depressive symptoms 46.27% (n = 31). Of
the children with high occurrence of depressive symptoma-
tology, ﬁve (11.63%) were undergoing chronic peritoneal
dialysis and two (8.33%) were undergoing hemodialysis. All
(100%) of the children with high occurrence of depressive
symptomatology were female (P = 0.04), and none of the
seven(0%)hadafriendtoconﬁdein(P = 0.03)(Table 1 and
Figure 1). The occurrence of depressive symptomatology in
patients with CPD was associated with a lower weekly Kt/V
compared to those with absence of depressive symptomatol-
ogy (2.15 ±0.68 versus 2.52 ±0.65; P = 0.01) (Table 2).
Twenty (83.33%) of the children undergoing hemodial-
ysis were from Lima, and 25 (58.14%) of the children
undergoing chronic peritoneal dialysis were from a province
outside the capital (P = 0.02). Of the patients undergoing
chronic peritoneal dialysis, 35 (81.40%) had both parents,
but ﬁve (11.63%) had only one parent, giving a P = 0.027
(Table 3).
We found some relationship between high occurrence
of depressive symptomatology and feelings, as follows: not4 International Journal of Nephrology
Table 3: Features according to dialysis types.
Variable Total HD DP P
% n % n %
Birleson Scale
High occurrence of depressive symptomatology 10.45 2 8.33 5 11.63
0.65 Low occurrence of depressive symptomatology 43.28 9 37.5 20 46.51
Absence of depressive symptomatology 46.27 13 54.17 18 41.86
Provenance
Lima 56.71 20 83.3 18 41.86 0.002
Other cities 43.28 4 16.7 25 58.14
Family
Two-parent home 70.14 12 50 35 81.4
0.027 One-parent home 19.40 8 33.3 5 11.63
Others 10.46 4 16.7 3 6.98
Table 4: Correlation of depressive symptoms with satisfaction with
their physical appearance, studies, economic status, and friendship.
Satisfaction with themselves Very Somewhat Not very P
Physical appearance
Absence of depressive
symptomatology
48.39% 6.45% 45.16%
0.041
Low occurrence of
depressive symptoms
41.38% 10.34% 48.28%
High occurrence of
depressive symptoms
0% 42.86% 57.14%
Studies
Absence of depressive
symptomatology
35.48% 9.68% 54.84%
0.001
Low occurrence of
depressive symptoms
17.24% 24.14% 58.62%
High occurrence of
depressive symptoms
0% 85.71% 14.29%
Economic status
Absence of depressive
symptomatology
32.26% 16.13% 51.61%
0.001
Low occurrence of
depressive symptoms
0% 34.48% 65.52%
High occurrence of
depressive symptoms
0% 71.43% 28.57%
Friendship
Absence of depressive
symptomatology
58.06% 12.9% 29.03%
0.001
Low occurrence of
depressive symptoms
37.93% 13.79% 48.28%
High occurrence of
depressive symptoms
0.00% 85.71% 14.29%
very happy with their physical appearance (4, 57.14%) P =
0.04, somewhat with their studies (6, 85.71%) P = 0.001,
somewhat unhappy with their ﬁnancial status (5, 71.43%)
P = 0.001, and somewhat unhappy with their friends (6,
85.71%) P = 0.001 (Table 4).
According to the Modiﬁed Birleson Scale (Table 5),
children with high recurrence of symptomatology answered
“always” the following questions: Number 21 (85.7%, n = 6)
and Number 5, 10, 12, 16, 17, 19, and 20 (100%, n = 7).
Children with low recurrence of symptomatology answered
all questions in a random way, including the questions
Number 10 and 21.
The presence of high and low occurrence of depressive
symptomatology was not related to the patient’s age, care-
giver’s age, dialysis period, presence of anemia, bone disease,
nutritional status, ﬁnancial situation, origin, schooling, or
employment.
4. Discussion
Having a chronic disease during childhood confers a large
risk of developing a psychiatric disorder, and chronic renal
disease is not an exception: it is a signiﬁcant stressor with
a psychological and social impact on the children and their
family [10].
In this study, we found a general frequency of 53.73% for
high and low depressive symptomatology, 10.45% for high
depressive symptomatology and 43.28% for low depressive
symptomatology, of whom 11.63% were undergoing peri-
toneal dialysis and 8.33% hemodialysis.
Bakr et al. [9] analyzed 19 children with chronic renal
insuﬃciency undergoing predialysis and 19 children with
terminal chronic renal insuﬃciency undergoing dialysis,
ﬁnding a 52.6% prevalence of psychiatric disorders, 18.4%
of adaptation disorders, 10.3% of depression, and 7.7% of
neurocognitivedisorders.However,inchildrenwithterminal
chronic renal insuﬃciency, depression was as high as 15.8%;
the authors also found a higher prevalence in dialysis
patients (68.4%) than in predialysis patients (36.8%). In
addition, Fukunishi and Kudo [12] reported that 17 (65.4%)
of 25 children with terminal chronic renal insuﬃciency
undergoing peritoneal dialysis had psychiatric disorders;
however,theydidnotanalyzethedepressionfrequency.Wass
and colleagues [13] found that of 26 British children who
were receiving hemodialysis at home, ﬁve (19.2%) had a psy-
chiatric disease. Another study, by Garralda and colleagues,
showed that psychiatric alterations such as depression are
common in children and adolescents (22 children andInternational Journal of Nephrology 5
Table 5: Modiﬁed Scale of Birleson and frequency of symptoms of the 67 patients; it is presented as an original sample, and it has been
literally translated in order to have a better understanding of depressive symptomatology. Always have a score of 2, sometimes of 1, and
never of 0.
Questions Equivalent in English
%
Always Sometimes Never
(1) Las cosas me gustan, me interesan
como antes
I like and am still interested in the same
things as before
34.32 (n = 23) 59.70 (n = 40) 5.97 (n = 4)
(2) Duermo muy bien I sleep well 64.18 (n = 43) 31.34 (n = 21) 4.47 (n = 3)
(3) Me dan ganas de llorar I feel like crying 11.94 (n = 8) 55.22 (n = 37) 32.83 (n = 22)
(4) Para adolescentes: me gustan salir
com amigos. Para ni˜ nos: me gusta salir a
jugar
For adolescents: I like going out with my
friends. For children: I like going out to
play
38.80 (n = 26) 35.82 (n = 24) 25.37 (n = 17)
(5) Me gustaria escapar, salir corriendo I would like to run away 10.45 (n = 7) 29.85 (n = 20) 59.70 (n = 40)
(6) Me duele la barriga, cabeza y otros
s´ ıtios de mi cuerpo
My stomach and my head hurt, as well as
other parts of my body
5.97 (n = 4) 41.79 (n = 28) 52.23 (n = 35)
(7) Tengo ganas para hacer las cosas I have a desire to do things 37.32 (n = 25) 50.74 (n = 34) 11.94 (n = 8)
(8) Disfruto de la comida I enjoy eating food 55.22 (n = 37) 38.80 (n = 26) 5.97 (n = 4)
(9) Puedo defenderme por mi mismo I am able to defend myself 43.28 (n = 29) 38.80 (n = 26) 17.91 (n = 12)
(10) Pienso que no vale la pena vivir I feel that life is not worth living 16.42 (n = 11) 28.35 (n = 19) 55.22 (n = 37)
(11) Soy bueno para las cosas que hago I am good at the things I do 47.76 (n = 32) 41.79 (n = 28) 10.44 (n = 7)
(12) Me molesto y me irrito por cualquier
cosa
I feel bothered and irritated with
everything
23.88 (n = 16) 55.23 (n = 37) 20.89 (n = 14)
(13) Disfruto lo que hago tanto como lo
hacia antes I still enjoy doing things as I did before 43.29 (n = 29) 47.76 (n = 32) 8.95 (n = 6)
(14) Me he vuelto olvidadizo y distra´ ıdo I have become forgetful and listless 7.46 (n = 5) 55.22 (n = 37) 37.32 (n = 25)
(15) Tengo sue˜ nos horribles I have nightmares 4.47 (n = 3) 35.82 (n = 24) 59.70 (n = 40)
(16) Pienso que haga lo que haga no
lograre conseguir lo que deseo o que las
cosas no van a cambiar
I think that it does not matter what I do; I
will never be able to accomplish the
things I want to accomplish; things are
never going to change
31.34 (n = 21) 31.34 (n = 21) 37.32 (n = 25)
(17) Me siento muy solo I feel very lonely 11.94 (n = 8) 37.31 (n = 25) 50.74 (n = 34)
(18) Puedo alegrarme facilmente I become happy easily 41.79 (n = 28) 50.74 (n = 34) 7.46 (n = 5)
(19) Me siento tan triste que me cuesta
trabajo soportarlo I feel so sad that I can hardly stand it 20.91 (n = 14) 28.35 (n = 19) 50.74 (n = 34)
(20) Me siento muy aburrido I feel very bored 16.42 (n = 11) 58.21 (n = 39) 25.37 (n = 17)
(21) Pienso muy serio en la muerte o en
matarme
I seriously think about death and killing
myself
8.95 (n = 6) 19.41 (n = 13) 71.64 (n = 48)
Total
adolescents with terminal chronic renal insuﬃciency and 22
predialysis children and adolescents with chronic rena in-
suﬃciency, compared to healthy children) and that these in-
crease in those whose renal disease is more severe [14].
Children with terminal chronic renal insuﬃciency have
growth retardation and develop secondary sexual character-
istics, bone deformities, multiple scars, and so forth. As a
consequence of bone dystrophy, uremia, and the treatment,
the children look and feel diﬀerent from other children, thus
increasingtheriskofpsychiatricproblemssuchasdepression
[15].
Before puberty, depression is more frequent in males,
while in the postpuberty period it predominates in females.
This is consistent with our results, where all of the children
with high occurrence of depressive symptomatology were
female and their average age was 14.76 ± 2.71. This diﬀers
from other studies that did not ﬁnd any relationship with
gender [4, 10].
Peritoneal dialysis patients without depressive symp-
tomatology had a better Kt/V value than patients with de-
pressive symptomatology, which was signiﬁcant (P = 0.01).
We could infer that depression as comorbidity is a negative
clinical factor. Another study did not show any relationship
with Kt/V [16]. There is evidence that suboptimal dial-
ysis increases mortality in patients undergoing peritoneal
dialysis and hemodialysis with cardiac, cerebral, and other
comorbidities. A Kt/V that diminishes by 0.1 weekly is
associated with a 5% increase in relative death risk [8, 17],6 International Journal of Nephrology
and suboptimal dialysis contributes to the risk of depression
[11, 18–20]. This ﬁnding needs to be clariﬁed in further
studies.
None of the children with high occurrence of depressive
symptomatologyhadafriendtoconﬁdein(P = 0.03),which
agrees with other studies. This conﬁrms that social support
contributes to the patient’s quality of life and decreases the
number of hospitalizations in children with chronic renal
insuﬃciency [21].
When asked How content or happy are you with your
physical appearance, studies, ﬁnancial status, and friends? (
P<0.05), they answered “more or less (content or happy)”
or “fairly (content or happy).” This conﬁrms the presence
of low self-esteem related to high occurrence of depressive
symptomatology, as the response “more or less” might be
considered “fair” because patients tend to deny depression
as a social defense [8, 10].
We know that the stress and impact of disease generate
a distressing and downcast reaction and/or pain in children
and their families. This is where the depressive symptoms
predominateandthendeveloptodepressionorotherpsychi-
atricchanges[22].Itisforthisreasonthatitisrecommended
that all children with depression, depressive symptoms, and
suicidal ideation according to the Modiﬁed Birleson Scale
or high and low depressive symptomatology according to
the recategorization should undergo psychiatric interview to
conﬁrm their probable diagnosis. As we know, depression is
a clinical diagnosis and the Modiﬁed Birleson Scale gives us
information about the presence of depressive symptoms, not
clinical depression itself. It can be used as a tool to help us
to be aware of any possible disorder, which would then need
to be conﬁrmed by a psychiatrist. Future research needs to
validate self-reported questionnaires in patients with chronic
disease like ESRD patients. A few studies show an increased
frequency of depression diagnosis after psychiatric interview
compared with frequency of possible depression after self-
completion of a diagnostic scale [23]. Such individuals
should be candidates for treatment, since there is evidence
thatsocial,psychological,andpharmacologicalinterventions
reduce mortality, morbidity, and treatment withdrawal [24],
and improve the quality of life [11, 25] associated with
depression in patients with or without comorbidities [26].
Giventhis,diagnosisofdepressionshouldalwaysbeincluded
in screening of pediatric patients with terminal chronic renal
insuﬃciency [8].
5. Conclusion
The frequencies of high and low occurrence of depressive
symptomatology were 10.45% and 43.28%, respectively.
The clinical and sociodemographic factors related to high
occurrence of depressive symptomatology were female sex,
havingornothavingafriendtoconﬁdein,anddialysisdose.
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